ZOM Zomedica Corp

Item 5.07 Submission of Matters to a Vote of Security Holders.

On June 7, 2022, Zomedica Corp. (the “Corporation”) held its Annual Virtual-Only Meeting of the holders (the “Shareholders”) of common shares (“Common Shares”) of the Corporation (the “Annual Meeting”). The matters voted on at the Annual Meeting were: (i) the election of directors of the Corporation, (ii) the appointment of Grant Thornton LLP as the Corporation’s auditors, (iii) the approval of, on an advisory basis, the executive compensation of the Corporation’s named executive officers and (iv) the approval of, on an advisory basis, how often the Corporation will conduct an advisory vote on executive compensation. Shareholders representing 294,570,954 shares, or 30.1%, of the Common Shares outstanding as of the April 18, 2022 record date were represented at the Annual Meeting in person or by proxy. The proposals are described in detail in the Corporation’s definitive proxy statement for the Annual Meeting (described as the Management Information Circular and Proxy Statement) filed with the Securities and Exchange Commission on April 26, 2022. The final voting results were as provided below. For purposes of providing percentage information below, any Common Shares that were the subject of abstentions or broker non-votes have been ignored in accordance with Canadian law. Therefore, the percentages reflected in relation to proposals 1 and 2 reflect only votes “for” or “withheld,” the percentages reflected in relation to proposal 3 reflect only votes “for” or “against,” and the percentages reflected in relation to proposal 4 reflect only votes for “1 Year,” “2 Years,” or “3 Years.”